Stockreport

Director of TScan Therapeutics Barbara Klencke Buys 18% More Shares [Yahoo! Finance]

TScan Therapeutics, Inc.  (TCRX) 
PDF NASDAQ:TCRX ) recently shelled out US$56k to buy stock, at US$5.61 per share. While we're hesitant to get too excited about a purchase of that size, we do note it increa [Read more]